XML 22 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation
 6 Months Ended
Jul. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
The stock-based compensation costs that have been charged against income were as follows (in thousands):

13-Weeks Ended26-Weeks Ended
July 30,
2022		July 31,
2021		July 30,
2022		July 31,
2021
Stock-based compensation expense by type:
Stock options
$— $— $155 $174 
Restricted stock units1,488 1,092 3,613 2,880 
Employee stock purchases
77 24 235 108 
Director deferred compensation24 15 41 21 
  Total stock-based compensation expense1,589 1,131 4,044 3,183 
Income tax benefit recognized369 279 926 758 
  Stock-based compensation expense, net of income tax$1,220 $852 $3,118 $2,425 

Expense for restricted stock units is shown net of forfeitures which were immaterial for the 13-weeks and 26-weeks ended July 30, 2022 and July 31, 2021.
We granted the following equity awards:
13-Weeks Ended26-Weeks Ended
July 30,
2022		July 31,
2021		July 30,
2022		July 31,
2021
Stock options
— — 7,212 4,384 
Restricted stock unit awards
1,673 790 109,521 62,031 
Performance-based restricted stock unit awards
— — 49,978 22,492 
Deferred stock units
532 174 937 258 
At July 30, 2022, the total compensation cost not yet recognized related to unvested restricted stock unit awards was $11.1 million and the weighted-average period over which such awards are expected to be recognized was 2.2 years. There were no unrecognized compensation costs related to unvested stock options at July 30, 2022.

The weighted-average grant date fair value of stock options granted during the 26-weeks ended July 30, 2022 and July 31, 2021 was $21.46 and $39.73 per share, respectively.
Under the Hibbett, Inc. Amended and Restated Non-Employee Director Equity Plan, no shares of our common stock were awarded during the 13-weeks ended July 30, 2022 and 6,388 shares of our common stock were awarded during the 26-weeks ended July 30, 2022. No shares of our common stock were awarded during the 13-weeks or 26-weeks ended July 31, 2021.
The number of shares purchased, the average price per share and the weighted-average grant date fair value of shares purchased through our employee stock purchase plan were as follows:
13-Weeks Ended26-Weeks Ended
July 30,
2022		July 31,
2021		July 30,
2022		July 31,
2021
Shares purchased7,352 2,063 21,625 9,508 
Average price per share$36.07 $58.56 $52.62 $43.44 
Weighted-average fair value at grant date$10.65 $11.39 $15.52 $11.44